journal article·2017-06

The covalent and non-covalent conjugation of graphene oxide with hydroxycamptothecin in hyperthermia for its anticancer activity

Magdalena Jedrzejczak-Silicka, Karolina Urbas, Ewa Mijowska, Rafał Rakoczy

Publisher page

Abstract

Abstract Many studies have focused on the possibility of applying graphene oxide as an effective drug delivery system, but also as an effective tool for a thermally-responsive system. Thus, the main aim of the study was to evaluate the cellular response of the MCF-7 cell line to covalently and non-covalently conjugated graphene oxide with hydroxycamptothecin (GO-HCPT) and the effect of an 8-h rotating magnetic field (RMF) exposure. The objective of this novel approach is to use graphene oxide platform not only as a drug delivery system, but also as an effective tool for a thermally-responsive system. The present study analyzed the effect of nanocomposites and RMF on the activity of MCF-7 cells and revealed that mitochondrial metabolism was significantly reduced in the cells incubated under all tested RMF parameters. In all tested variants of c-GO-HCPT concentrations and RMF inductions, cell viability was reduced by approximately 10–50% (data from WST-1 assay) for cells incubated with nanocomposite for 24 h and 70–90% for cells incubated with nanocomposite for 48 h. The observed LDH leakage was higher for cells exposed to c-GO-HCPT for longer incubation time. In the case of nc-GO-HCPT, the relative viability was reduced by 10–30%, respectively to the sample concentration and magnetic induction value for 48-h incubation. The data obtained in the NR assays after 24 h confirmed slightly higher cytotoxic co-effect of nc-GO-HCPT with cellular metabolism reduced by 90–98%. The concentration of nanomaterials also influenced mitochondrial metabolism. Both tested nanomaterials, c-GO-HCPT and nc-GO-HCPT, and RMF affected effectively the metabolism and viability of the cells, but not in a dose-dependent manner. A small difference in cellular response was observed in the presence of non-covalent and covalent GO-HCPT, with a slightly higher cytotoxicity effect of nc-GO-HCPT, visible 24 h after the experiment. These findings could have potential clinical application, including targeted tumor chemotherapy and thermal ablation.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Graphene research and applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Electric field effect in atomically thin carbon films10.1126/science.1102896 ↗
2. Graphene-based materials as supercapacitor electrodes10.1039/c000417k ↗
3. Biocompatibility of graphene oxide
4. Thermal properties of graphene and nanostructured carbon materials10.1038/nmat3064 ↗
5. Superior thermal conductivity of single-layer graphene10.1021/nl0731872 ↗
6. Extremely high thermal conductivity of graphene: prospects for thermal management applications in nanoelectronic circuits10.1063/1.2907977 ↗
7. Magnetic Fe3O4–graphene composites as targeted drug nanocarriers for pH-activated release10.1039/c2nr33158f ↗
8. Fluorescence dye loaded nano-graphene for multimodal imaging guided photothermal therapy
9. Covalent conjugation of graphene oxide with methotrexate and its antitumor activity10.1016/j.cplett.2013.03.050 ↗
10. A one-step strategy for thermal- and pH-responsive graphene oxideinterpenetrating polymer hydrogel networks10.1039/c1jm10276a ↗
11. Thermal transport in graphene oxide – from ballistic extreme to amorphous limit10.1038/srep03909 ↗
12. Thermal conductivity of graphene and graphene oxide nanoplatelets. IEEE Intersoc. Conf. Therm. Thermo-mech
13. Plant Antitumor Agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata1,210.1021/ja00968a057 ↗
14. Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine10.2174/092986707781368441 ↗
15. Mechanism of action of camptothecin10.1111/j.1749-6632.2000.tb07020.x ↗
16. Total synthesis of camptothecin and Sn-3810.1021/jo201974f ↗
17. A small-sized graphene oxide supramolecular assembly for targeted delivery of camptothecin10.1039/C4CC04533E ↗
18. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery10.1016/j.addr.2011.03.008 ↗
19. Inductive heating property of graphene oxide-Fe3O4 nanoparticles hybrid in an AC magnetic field for localized hyperthermia10.1016/j.matlet.2011.11.013 ↗
20. Improved synthesis of graphene oxide10.1021/nn1006368 ↗
21. Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity10.1021/nn9005686 ↗
22. Mixing energy investigations in a liquid vessel that is mixed by using a rotating magnetic field10.1016/j.cep.2013.01.012 ↗
23. Raman spectroscopy in graphene10.1016/j.physrep.2009.02.003 ↗
24. Raman characterization of defects and dopants in graphene10.1088/0953-8984/27/8/083002 ↗
25. The origin of sub-bands in the Raman D-band of graphene10.1016/j.carbon.2012.05.008 ↗
26. Processable aqueous dispersions of graphene nanosheets10.1038/nnano.2007.451 ↗
27. Structural evolution during the reduction of chemically derived grapheneoxide10.1038/nchem.686 ↗
28. Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene oxide10.1016/j.colsurfb.2011.08.026 ↗
29. In vitro toxicity evaluation of graphene oxide on A549 cells10.1016/j.toxlet.2010.11.016 ↗
30. Anti-proliferative and apoptosis-inducing effects ofcamptothecin-20(s)-O-(2-pyrazolyl-1)acetic ester in human breast tumor MCF-7 cells10.3390/molecules19044941 ↗
31. A novel camptothecin analog with enhanced antitumor activity
32. Ab initio study on the noncovalent adsorption of camptothecin anticancer drug onto graphene oxide, defect modified graphene and graphene oxide10.1007/s10822-013-9681-3 ↗
33. Critical analysis of data concerning Saccharomyces cerevisiae free-cell proliferations and fermentations assisted by magnetic and electromagnetic fields
34. The influence of a ferrofluid in the presence of an external rotating magnetic field on the growth rate and cell metabolic activity of a wine yeast strain10.1016/j.bej.2016.01.002 ↗
35. Magnetoporation and magnetolysis of cancer cells via carbon nanotubes induced by rotating magnetic fields10.1021/nl301928z ↗
36. Exposure to high static or pulsed magnetic fields does not affect cellular processes in the yeast Saccharomyces cerevisiae10.1002/bem.20523 ↗
37. Exposure of cells to static magnetic field accelerates loss of integrity of plasma membrane during apoptosis10.1002/cyto.10160 ↗
38. The influence of static magnetic fields on canine and equine mesenchymal stem cells derived from adipose tissue10.1007/s11626-013-9730-1 ↗
39. The review of cellular effects of a static magnetic field10.1016/j.stam.2006.01.004 ↗
40. The cellular and molecular basis of hyperthermia10.1016/S1040-8428(01)00179-2 ↗
41. Calcium signalling and cell-fate choice in B cells10.1038/nri2172 ↗
42. Magnetic field assisted fluidization – a unified approach. Part 8. Mass transfer: magnetically assisted bioprocess10.1515/REVCE.2010.006 ↗
43. Response of preosteoblast to thermal stress condition and osteoinductive growth factors10.1007/s12192-011-0300-8 ↗
44. Weak electromagnetic fields (50 Hz) elicit a stress response in human cells10.1016/S0013-9351(03)00088-4 ↗
45. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models10.1016/j.mrrev.2015.01.001 ↗